ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Scientists repair spinal cord injuries using patients’ stem cells
February 24, 2021In a Phase II trial, all 13 patients who received an intravenous infusion of their own mesenchymal stem cells had improvements in neurological function six months later. -
AbbVie gets orphan drug and fast track status for elezanumab
October 09, 2020AbbVie has received orphan drug and fast track designations from the US Food and Drug Administration (FDA) for elezanumab (ABT-555) to treat spinal cord injury (SCI).
Pharma Sources Insight January 2025
